Elsevier

Life Sciences

Volume 51, Issue 24, 1992, Pages 1851-1856
Life Sciences

A cAMP-dependent protein kinase inhibitor modulates the blocking action of ATP and 5-hydroxydecanoate on the ATP-sensitive K+ channel

https://doi.org/10.1016/0024-3205(92)90036-OGet rights and content

Abstract

We studied the blocking mechanism of 5-hydroxydecanoate, a novel antiarrhythmic agent, on the ATP-sensitive K+ channel in the single ventricular myocytes using the inside-out patch clamp technique. The channel activity in response to 5-hydroxydecanoate varied with each membrane patch corresponding to the sensitivity to ATP. In this condition the exogenous application of cAMP or cAMP-dependent protein kinase (PKA) obviously recovered the ATP-sensitive K+ channel activity after channel deactivation. By contrast, in membrane patches exhibited low sensitivity to ATP, endogenous cAMP-dependent protein kinase inhibitor (PKI) depressed the channel activity and restored the inhibitory action of 5-hydroxydecanoate and ATP on the channel. These results suggest that PKA-PKI system is involved in the regulatory mechanism of gating activity of the ATP-sensitive K+ channel and the blocking action of 5-hydroxydecanoate and ATP appears to be exerted by potentiating the inhibitory action of PKI on the channel.

References (13)

  • C.D. Ashby et al.

    J. Biol. Chem.

    (1972)
  • I. Findlay

    Pflügers Arch.

    (1987)
  • T. Ohno-Shosaku et al.

    Pflügers Arch.

    (1987)
  • M. Takano et al.

    Am. J. Physiol.

    (1990)
  • A. Noma

    Nature

    (1983)
  • G-N. Tseng et al.

    Pflügers Arch.

    (1990)
There are more references available in the full text version of this article.

Cited by (14)

  • Mitochondrial K<inf>ATP</inf> channels in cell survival and death

    2005, Journal of Molecular and Cellular Cardiology
  • Guide to the pharmacology of mitochondrial potassium channels

    2017, Handbook of Experimental Pharmacology
View all citing articles on Scopus
View full text